86 related articles for article (PubMed ID: 9930861)
1. Live attenuated AIDS vaccines: hazards and hopes.
Johnson RP
Nat Med; 1999 Feb; 5(2):154-5. PubMed ID: 9930861
[No Abstract] [Full Text] [Related]
2. Attenuated retrovirus vaccines and AIDS.
Shearer GM; Lucey DR; Clerici M
Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
[No Abstract] [Full Text] [Related]
3. Attenuated retrovirus vaccines and AIDS.
Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
[No Abstract] [Full Text] [Related]
4. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
5. Live HIV vaccines--how safe?
Dittmer U; Stahl-Hennig C; Hunsmann G
Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262
[No Abstract] [Full Text] [Related]
6. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
Das AT; Zhou X; Vink M; Klaver B; Berkhout B
Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
[TBL] [Abstract][Full Text] [Related]
7. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
8. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
Baba TW; Liska V; Khimani AH; Ray NB; Dailey PJ; Penninck D; Bronson R; Greene MF; McClure HM; Martin LN; Ruprecht RM
Nat Med; 1999 Feb; 5(2):194-203. PubMed ID: 9930868
[TBL] [Abstract][Full Text] [Related]
9. Infectious vaccines.
Ross DW
Arch Pathol Lab Med; 1998 Jan; 122(1):100-1. PubMed ID: 9448028
[No Abstract] [Full Text] [Related]
10. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.
Puaux AL; Marsac D; Prost S; Singh MK; Earl P; Moss B; Le Grand R; Riviere Y; Michel ML
Vaccine; 2004 Sep; 22(27-28):3535-45. PubMed ID: 15315833
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccines. At conference, hope for success is further attenuated.
Cohen J
Science; 1994 Nov; 266(5188):1154. PubMed ID: 7973692
[No Abstract] [Full Text] [Related]
12. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
[No Abstract] [Full Text] [Related]
13. Attenuated retrovirus vaccines and AIDS.
Marx PA
Science; 1995 Nov; 270(5239):1219-20; author reply 1220-2. PubMed ID: 7502054
[No Abstract] [Full Text] [Related]
14. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
15. Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.
Desrosiers RC
J Int Assoc Physicians AIDS Care; 1998 Nov; 4(11):22-3. PubMed ID: 11366120
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated HIV vaccines: how safe is safe enough?
Murphey-Corb M
Nat Med; 1997 Jan; 3(1):17-8. PubMed ID: 8986728
[No Abstract] [Full Text] [Related]
17. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.
Das AT; Klaver B; Harwig A; Vink M; Ooms M; Centlivre M; Berkhout B
J Virol; 2007 Oct; 81(20):11159-69. PubMed ID: 17670816
[TBL] [Abstract][Full Text] [Related]
18. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
Pal R; Kalyanaraman VS; Nair BC; Whitney S; Keen T; Hocker L; Hudacik L; Rose N; Mboudjeka I; Shen S; Wu-Chou TH; Montefiori D; Mascola J; Markham P; Lu S
Virology; 2006 May; 348(2):341-53. PubMed ID: 16460776
[TBL] [Abstract][Full Text] [Related]
19. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
[TBL] [Abstract][Full Text] [Related]
20. [Live attenuated AIDS vaccine possibly lethal].
Ned Tijdschr Geneeskd; 1997 Nov; 141(44):2139. PubMed ID: 9644004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
